Public signalCompany raiseAuto-indexed · Unverified
Inflammasome Therapeutics, Inc. raised $13.2M
Inflammasome Therapeutics, Inc.· NEWTON, US· Biotechnology· Filed May 4, 2026
Inflammasome Therapeutics, Inc. reported raising capital. Based in NEWTON, MASSACHUSETTS, US. First sale reported 2026-02-27. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$13.2M
Confidence90%
On the record
- Location
- NEWTON, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $13.2M
- Target amount
- $13.2M
- Filing date
- May 4, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Sources & provenance
“Operating company sold 13,155,645 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated May 4, 2026. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with Inflammasome Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record